Related by context. All words. (Click for frequent words.) 72 fampridine 63 PEGylated Fab fragment 62 azacytidine 62 Methylnaltrexone 62 Interferon beta 1b 62 Orally administered 62 selective phosphodiesterase 61 racemic 61 Mg Usa 61 cis retinoic acid 61 MAO inhibitor 61 hormone agonist 60 Valproic acid 60 pimozide 60 ZOLINZA 60 luteinizing hormone releasing 60 Linagliptin 60 prescribed proton pump 59 ara C 59 PEGylated anti 59 EXPAREL TM 59 receptor modulator 59 factor TNF 59 deoxy 59 Recombinant Human 59 CDK inhibitor 59 cyclooxygenase 59 sitaxsentan 59 reuptake inhibitor 59 dexamethasone Decadron 59 Teriflunomide 59 liposomal formulation 59 Mg Uk 59 bromocriptine 59 octreotide acetate 59 naturally occurring molecule 59 selective A2A adenosine receptor 59 receptor blocker 59 Azacitidine 59 nonstimulant 59 N methyl 59 enzyme inhibitor 59 rhIGFBP 3 59 blood clotting protein 59 Natalizumab 59 Receptor Antagonists 59 interferon alfa 58 5 hydroxytryptamine 58 Zoloft sertraline 58 Vidaza azacitidine 58 Angiotensin II 58 Dasatinib 58 dihydrochloride 58 monoamine oxidase inhibitors 58 MEVACOR 58 Esomeprazole 58 Fibroblast Growth Factor 58 avidin 58 Ecallantide 58 nitrofurantoin 58 Galantamine 58 Angiotensin Converting Enzyme 58 Eltrombopag 58 PEGylated 58 immunosuppressant drug 58 MAOI 58 CYP#A# CYP#D# 58 SPRYCEL ® 58 cytokine signaling 58 generation antisense inhibitor 58 haloperidol Haldol 58 selective antagonist 58 fumarate 58 itraconazole 58 related apoptosis inducing 58 adalimumab Humira 58 ropinirole 57 flecainide 57 Sitagliptin 57 dihydrofolate reductase 57 angiogenesis inhibitor 57 ONGLYZA saxagliptin 57 Randomized Phase 57 enzyme phosphodiesterase 57 lamotrigine Lamictal 57 systemically administered 57 GW# [003] 57 MAGE A3 ASCI 57 antifibrotic 57 DFMO 57 Interferon gamma 57 nucleotide analogue 57 protein tyrosine phosphatase 1B 57 TNF Tumor Necrosis Factor 57 interferon beta 57 CYP #A# 57 Voreloxin 57 ADP receptor antagonist 57 2A receptor agonist 57 clomipramine 57 receptor inhibitor 57 NFkappaB 57 pharmacokinetic interactions 57 pimecrolimus cream 57 riociguat 57 N acetyl 57 Degarelix 57 Adalimumab 57 paroxetine Paxil 57 Ganciclovir 57 #ß 57 thyrotropin 57 selective modulator 57 Tocilizumab 57 cholecystokinin CCK 57 mycophenolate mofetil 57 Peg IFN 57 interferon alfa 2b 57 PENTASA 57 Angiotensin 57 Safinamide 57 ERK1 2 57 sertraline Zoloft 57 Endothelin 57 GLP1 agonist 57 rivastigmine Exelon 57 Calcitonin 57 oral JAK1 57 Decitabine 57 zaleplon 57 anti androgen 56 intercellular adhesion molecule 56 aripiprazole Abilify 56 TORISEL 56 incretin mimetic 56 Romiplostim 56 humanized interleukin 6 56 HT 1A 56 cyclooxygenase COX 56 Rebif ® 56 biologic DMARD 56 Teriparatide 56 Leukine ® 56 small molecule Hedgehog 56 sodium glucose cotransporter 56 basal bolus regimen 56 beta adrenergic 56 methoxy 56 MTP inhibitor 56 ZYVOX 56 pharmacologically active isomer 56 gonadotropin releasing hormone GnRH 56 bone morphogenetic protein 56 Granulocyte Colony Stimulating Factor 56 hour bronchodilation 56 interleukin IL -# 56 small molecule activators 56 tigecycline 56 SCIg 56 Diabetic Nephropathy 56 glycogen synthase kinase 56 Serious adverse reactions 56 Levetiracetam 56 acetylcholinesterase inhibitor 56 evaluating tivozanib 56 Chemokine Receptor 56 oral prodrug 56 teriflunomide 56 Parathyroid Hormone 56 Doxepin 56 Raltegravir 56 Vandetanib 56 immune modulator 56 chimeric monoclonal antibody 56 sorafenib Nexavar 56 enkephalin 56 PDE1 56 E1 INT TM 56 fluticasone furoate 56 Xelox 56 MULTAQ 56 Fingolimod 56 muscarinic receptor 56 prostaglandin E2 PGE2 56 isoprostane 56 maleate 56 intranasal delivery 56 busulfan 56 Enzastaurin 56 anti CD3 antibody 56 cinacalcet 56 D aspartate NMDA receptor 56 HMG CoA reductase inhibitors 56 memantine Namenda 56 beta 1a 56 inhibitor rofecoxib 56 visilizumab 56 cytochrome P# #A# 56 receptor partial agonist 56 Pafuramidine 56 selective adenosine 56 Copegus ribavirin 56 diabetic gastroparesis 56 Sudhir Agrawal D.Phil 56 bexarotene 56 phenothiazines 56 Cimzia ® certolizumab pegol 56 aminolevulinic acid 56 diarrhea predominant irritable 56 entacapone 56 VFEND 56 Histamine 56 glucuronide 56 dorzolamide 56 Bezielle 56 anti CTLA 56 hormone LHRH 56 ACE Inhibitors 56 infliximab Remicade 56 interferon IFN 56 5alpha reductase 56 TLK# 56 Hycamtin ® 56 cortisol synthesis 56 SIMCOR 56 Factor Receptor 56 oral antidiabetic 56 MEK1 56 PSMA ADC 55 antiarrhythmic 55 soluble tumor necrosis 55 serotonin reuptake 55 TLR9 agonist 55 IFN alpha 55 idraparinux 55 CTAP# Capsules 55 NovoLog ® Mix 55 VSL # 55 receptor inhibiting monoclonal 55 Ramelteon 55 uricase 55 Vaprisol 55 oxcarbazepine 55 divalproex sodium 55 Rotigotine 55 SGPT 55 ALK inhibitor 55 Infusion Reactions Severe 55 intranasal formulation 55 selective inhibition 55 LAF# 55 Tezampanel 55 JZP 55 piperacillin tazobactam 55 Tumor Necrosis Factor 55 mineralocorticoid receptor 55 partial agonist 55 acetylcholinesterase 55 Dacogen decitabine 55 Crizotinib 55 dipeptidyl peptidase 4 55 Pathway Inhibitor 55 hypereosinophilic syndrome 55 GLP1 55 PC DAC Exendin 55 acetylcholine receptor 55 refractory gout 55 vesicular monoamine transporter 55 nucleoside analogues 55 laropiprant 55 Theophylline 55 VAPRISOL 55 Known generically 55 endothelin receptor 55 LRAT 55 VEGF receptor 55 Glucagon Like Peptide 55 ganciclovir 55 gadobutrol 55 Tumor necrosis factor 55 MGd 55 eotaxin 55 Interferon Beta 55 Aripiprazole 55 FENTORA 55 NeuroSTAT ® 55 #HT#A 55 Inhalation Solution 55 Lubiprostone 55 Amiodarone 55 cytochrome P 55 methionine aminopeptidase 55 QTc prolongation 55 direct thrombin inhibitors 55 lysosomal enzyme iduronate 55 hematologic toxicity 55 interleukin IL -6 55 Factor VEGF 55 LY# [003] 55 myelofibrosis polycythemia vera 55 muscarinic receptors 55 Janus kinase 55 Aflibercept 55 neutrophil recruitment 55 MNTX 55 ADAMTS# 55 neutropenic fever 55 Belimumab 55 prostanoid 55 Prolactin 55 deferiprone 55 salmeterol fluticasone 55 nelfinavir Viracept 55 norepinephrine reuptake inhibitor 55 5HT 55 novel VDA molecule 55 Phosphodiesterase 55 2DG 55 prucalopride 55 Ranolazine 54 guanfacine extended release 54 β2 54 angiotensin II receptors 54 brivanib 54 acarbose 54 BAY #-# 54 interleukin IL 54 kallikrein 54 ACIPHEX 54 Vfend 54 postprandial glycemia 54 pomalidomide 54 Genentech Rituxan 54 ULORIC 54 mertansine 54 PDE4 inhibitor 54 TNF receptor 54 GPIIb IIIa 54 Bosutinib 54 peptide CGRP 54 etidronate 54 Tasimelteon 54 cediranib 54 IGFBP 3 54 TÎ ² 4 54 Rivastigmine 54 edifoligide 54 AAG geldanamycin analog 54 fluvastatin 54 INCB# [003] 54 receptor blockers 54 hypoxia inducible factor 54 GHRH 54 receptor subtype 54 orally administered inhibitor 54 Spironolactone 54 IFN α 54 EOquin TM phase 54 CANCIDAS 54 IL 1β 54 Pharmacokinetic parameters 54 AGHD 54 sitosterol 54 TYGACIL 54 mg/# h 54 monocyte chemotactic protein 54 metalloproteinase 54 Vascular Endothelial Growth 54 collagenase 54 5 HT2A serotonin 54 opioid receptor antagonist 54 #mg dose [002] 54 crizotinib PF # 54 MCyR 54 Aldosterone 54 TNF á 54 TNF antagonist 54 Kepivance 54 coronary vasodilation 54 Pivotal Phase 54 Omalizumab 54 VEGF receptors 54 Rosiglitazone 54 synthetic analogues 54 nicotinic 54 standard chemotherapy regimen 54 isoenzyme 54 interleukins 54 Saxagliptin 54 Janus Kinase 54 cytokine interleukin 54 Alphanate R 54 SGLT 54 nucleotide analog 54 Sapacitabine 54 PKC inhibitor 54 serotonin receptor 54 ALGRX 54 Desvenlafaxine 54 Piperacillin 54 phosphodiesterase PDE 54 CDK4 54 inhibiting COX 54 antiangiogenic 54 Inhalation Powder 54 Boceprevir 54 Ophena TM 54 Maribavir 54 brivaracetam 54 mTOR mammalian target 54 BYETTA exenatide injection 54 Xanax alprazolam 54 Venlafaxine 54 metabotropic glutamate receptor 54 Indomethacin 54 cyclin dependent kinase CDK 54 5 lipoxygenase 54 thymalfasin 54 DETROL LA 54 Abacavir 54 serotonin norepinephrine reuptake inhibitors 54 LY# [002] 54 doxazosin 54 somatostatin analog 54 Dabigatran etexilate 54 NKX2 54 cobiprostone 54 ACTOS ® 54 Vimpat R 54 caspofungin 54 Darapladib 54 gonadotrophin releasing hormone 54 TNFalpha 54 DMARDS 54 selective agonist 54 CORT # 54 HuMax EGFr 53 Cholinesterase Inhibitors 53 nucleoside analog 53 Xanafide 53 Panzem R 53 orally bioavailable 53 Talabostat 53 Lisofylline LSF 53 alpha2 53 liposomal amphotericin B 53 inhibitor COX 53 inflammatory PDE 53 JAK Inhibitor 53 insulin sensitizers 53 Zoledronic acid 53 pegylated interferon alpha 53 dose proportional pharmacokinetics 53 Formoterol 53 polymerase inhibitor 53 GABITRIL 53 muscarinic 53 prostaglandin D2 53 peginterferon alfa 53 incretin mimetics 53 GAMMAGARD 53 Everolimus 53 antisense inhibitor 53 nelfinavir 53 Interferon alpha 53 LHRH agonists 53 PI3K/Akt pathway 53 Bicalutamide 53 CYT# potent vascular disrupting 53 baclofen 53 IL 1ß 53 peptibody 53 mevalonate 53 immunomodulatory therapy 53 cytokines IL 53 Zileuton 53 Glucocorticoids 53 5 HT2A receptor 53 Tubulin 53 proliferator activated receptor 53 methylnaltrexone 53 TELINTRA 53 Topiramate 53 colesevelam HCl 53 antimuscarinic 53 novel synthetic peptide 53 NN# [001] 53 Dapagliflozin 53 Initiate Phase 53 PKC beta 53 ATL# [002] 53 tocilizumab 53 IFN beta 53 TNFa 53 protein interleukin 53 acyclovir Lauriad R 53 Galectin 53 polycystin 53 hormone GLP 53 fibulin 53 ,#,# [002] 53 Focalin XR 53 cell adhesion molecule 53 HER2 overexpression 53 colony stimulating factor 53 vardenafil Levitra 53 PRADAXA 53 YONDELIS 53 alpha blocker 53 Cholinesterase inhibitors 53 plasminogen activator inhibitor 53 receptor antagonists 53 Factor Xa 53 PTH1 53 interferon gamma 1b 53 A2A receptor 53 terlipressin 53 Omacetaxine 53 factor Xa 53 JAK2 enzyme 53 IAP inhibitor 53 Cariprazine 53 Akt activation 53 TNF α 53 PDGFR 53 JAK inhibitor 53 pancreatic alpha 53 Interferon alfa 53 selective inhibitor 53 mTOR inhibitors 53 RSD# 53 QT prolongation 53 calcineurin inhibitors 53 insulin sensitizing 53 norethindrone 53 somatostatin 53 PDE#A 53 reversible inhibitor 53 synthetic retinoid 53 lipoxygenase 53 TriRima 53 hydroxylase 53 alpha TNF 53 t# c# CLA 53 RECOTHROM R 53 DNA intercalator 53 forodesine 53 Cyclooxygenase 53 zileuton 53 oral phosphodiesterase type 53 methyl CpG binding 53 TRISENOX ® 53 DPP4 53 urocortin 2 53 canagliflozin 53 PEG IFN 53 relapsed MM 53 pharmacodynamic parameters 53 Remicade infliximab 53 Nifedipine 53 orally dosed 53 PTHrP 53 Macrophage 53 dasatinib Sprycel 53 5 HT4 53 Pivotal Phase III 53 systemic fungal infections 53 metaglidasen 53 nitrosothiols 53 angiotensin II receptor blocker 53 cIAI 53 Rigel R# 53 enzyme COX 53 medoxomil 53 receptor agonist 52 potential vanilloid 52 dopamine partial agonist 52 #beta HSD1 52 Survivin antagonist 52 cannabinoid receptor 52 dihydro 52 ocular formulation 52 Thrombin 52 antidiabetic 52 Tekturna HCT 52 pharmacological inhibition 52 receptor tyrosine kinase inhibitor 52 cyclin dependent kinases 52 huC# DM4 52 APOPTONE 52 lysophosphatidic acid 52 TREANDA 52 Panzem 52 glitazone 52 chronic eosinophilic leukemia 52 CIMZIA ™ 52 Dalbavancin 52 antisense oligonucleotide 52 somatostatin analogue 52 taxane resistant 52 Exforge HCT 52 MEK ERK 52 dual PPAR peroxisome 52 erlotinib Tarceva 52 receptor modulators 52 topical gel containing 52 Vernakalant 52 mg eq 52 rufinamide 52 Cytochrome P# 52 retapamulin 52 ACZ# 52 albiglutide 52 inducible nitric oxide synthase 52 balsalazide 52 leukotrienes 52 HuMax CD4 52 protein phosphatase 52 SPRIX ® 52 EGFr 52 LT NS# 52 pyridoxine 52 administered intranasally 52 ACC2 52 Carvedilol 52 extracellular signal 52 inhibitor RG# 52 histone deacetylase HDAC inhibitor 52 terazosin 52 prostaglandin synthesis 52 Gamunex C 52 IGFBP 52 pegylated IFN 52 SinuNase TM 52 Adenosine 52 Caspase 52 lumiliximab 52 DLTs 52 statin monotherapy 52 proteasome inhibitor 52 ELND# 52 cMET 52 olmesartan 52 Leukotrienes 52 adenosine receptor 52 Benazepril 52 histone deacetylase 52 beta1 52 potent vasodilator 52 anxiolytic 52 Receptor Agonist 52 annexin 52 heme oxygenase 52 Fibroblast Growth Factor Receptor 52 insulin sensitizer 52 RAPTIVA 52 TRAIL receptor 52 gonadotropin releasing hormone 52 Enbrel Humira 52 uncoupling protein 52 neurokinin 52 Alogliptin 52 GSK# [002] 52 matrix metalloproteinases MMPs 52 dexpramipexole 52 mg BID dose 52 PRISTIQ 52 Androxal TM 52 IL6 52 tricyclic antidepressants TCAs 52 endothelial nitric oxide synthase 52 receptor monoclonal antibody 52 Protease inhibitors 52 5 HT2A 52 delafloxacin 52 ZD# [001] 52 sargramostim 52 Sulfonylurea 52 midstage clinical 52 Micardis ® 52 ranitidine Zantac 52 agonist LABA 52 inhaled formulation 52 PEGylated interferon 52 HCV NS5B polymerase 52 SAR# [002] 52 phosphodiesterase 52 TOVIAZ 52 IFN γ 52 Iloperidone 52 R# #mg BID 52 RSD# iv 52 adrenoceptor 52 claudin 52 angiotensin receptor blocker ARB 52 calcitriol 52 potassium sparing diuretics 52 Fibrates 52 C1 INH deficiency 52 SGLT2 inhibitors 52 Fenofibrate 52 NMDA receptor antagonists 52 Phospholipase A2 52 HT 2A 52 calcineurin inhibitor 52 Clusterin 52 oral diclofenac 52 Lamictal ODT 52 prostaglandin E 52 sodium thiosulfate STS 52 glucose transporter 52 Sugammadex 52 alpha 2A 52 naturally occurring protein 52 FOSRENOL ® 52 binding protein IGFBP 52 EOquin TM 52 SinuNase ™ 52 thrombin receptor 52 Axid 52 Glucagon 52 SGLT1 52 oral rivaroxaban 51 Cyclooxygenase 2 51 xanthine 51 OVER FINANCIAL REPORTING 51 Prodarsan ® 51 phospholipase 51 PSN# [001] 51 poly ADP ribose polymerase 51 Solulin 51 daptomycin 51 benzothiazole 51 Bifeprunox 51 VA# [002] 51 glucocorticoid receptor 51 Cellcept 51 Atrasentan 51 RezularTM 51 cyclo oxygenase 51 BLyS specific 51 integrin alpha 51 cannabinor 51 Tumor Response 51 CYP#A# [002] 51 Protein Kinase C 51 Orexin 51 Kahalalide F 51 Lixivaptan 51 lintuzumab SGN 51 Plicera 51 BENICAR HCT 51 Aclidinium 51 vWF 51 Factor NGF 51 Rasagiline 51 heme oxygenase 1 51 Cleviprex TM clevidipine 51 PPAR gamma agonists 51 Somatuline R Depot 51 antidepressant efficacy 51 PDE4 51 leucine isoleucine 51 Alanine 51 GATTEX ® 51 TNF IL 51 ALN HPN 51 antihyperglycemic 51 macrolide antibiotics 51 troglitazone 51 gastrointestinal toxicities 51 PDE5A 51 posaconazole 51 nitroprusside 51 vWD 51 tumor xenograft models 51 factor VIIa 51 DHFR 51 novel histone deacetylase 51 Civacir 51 reslizumab 51 serine threonine 51 Monopril 51 Completes Patient Enrollment 51 vasoconstrictor 51 TREDAPTIVE 51 ADDITIONAL FINANCING REQUIREMENTS 51 targeted radiotherapeutic 51 rxRNA 51 HCV SPRINT 51 K ras mutations 51 oral allopurinol 51 M1 muscarinic 51 PNP inhibitor 51 Azactam 51 HCV replicon 51 Argatroban 51 peripherally restricted 51 myeloproliferative diseases 51 calcitonin gene related 51 LPA1 receptor 51 PTP 1B 51 APTIVUS 51 PDE inhibitors 51 immunomodulator 51 adipiplon 51 complete cytogenetic response 51 agonist 51 LTB4 51 receptor subtypes 51 CGRP 51 reverse transcriptase inhibitors 51 e# DOI #.#/journal.pone.# 51 selective antagonists 51 dihydrotestosterone 51 TLR9 51 MKC# MT 51 receptor agonists 51 cytokine IL 51 trastuzumab Herceptin R 51 RTP #i 51 HIF 1a 51 receptor kinase 51 tafamidis 51 regulated kinase 51 anaplastic lymphoma kinase 51 muraglitazar 51 non nucleoside HCV 51 Nedd4 51 aminosalicylates 51 delta gamma agonist 51 Targretin capsules 51 Roche Actemra 51 nicotinic receptor 51 HuLuc# 51 Nicotinic acid 51 LymphoStat B belimumab 51 Vagifem 51 ATPace TM 51 AT1R 51 LB# [003] 51 TIMP 1 51 Azedra 51 mealtime insulin 51 MIF protein 51 CCR2 51 Azilect ® 51 leukotriene 51 Gammagard Liquid 51 sphingosine kinase 51 Silodosin 51 adhesion molecule 51 matrix metalloproteinase 51 including eniluracil ADH 51 Velcade bortezomib 51 upregulates 51 chemically modified siRNA 51 nitric oxide synthase 51 incretin 51 GABA receptor 51 E selectin 51 Brain Derived Neurotrophic 50 cyclin dependent kinase inhibitor 50 rhIGF 50 EGFR HER2 50 MetAP 50 low dose cytarabine 50 selective serotonin 2C receptor 50 glucagon receptor 50 glycated hemoglobin levels 50 Personalized Immunotherapy 50 neurotrophic factor 50 Hypoxia Inducible Factor 50 saquinavir 50 sphingosine 1 50 injectable formulations 50 protein tyrosine phosphatases 50 XOMA 3AB 50 Lp PLA 2 50 neurofibromin 50 Solorel TM 50 Roflumilast 50 Cathepsin S 50 Erythropoietin 50 Tolamba 50 peroxisome proliferator activated 50 vildagliptin 50 casein kinase 50 PTP1B 50 anti inflammatory cytokine 50 RAPAFLO 50 Aptivus ® 50 KNS # 50 eIF4E 50 NPH insulin 50 VEGFR1 50 phosphate S1P 50 pyruvate kinase 50 azilsartan medoxomil 50 HGS ETR2 50 mGluR2 50 PDE5 inhibitor 50 protein encoded 50 Catenin 50 histone deacetylases 50 Actimmune ® 50 oral dihydropyrimidine dehydrogenase DPD 50 aripiprazole 50 NMDA receptor 50 angiotensin receptor blockers ARBs 50 XP# XP# 50 BCR ABL 50 PRT# 50 plasminogen activators 50 myocyte enhancer factor 50 DCCR 50 ancrod 50 arginine vasopressin AVP 50 cyclooxygenase 2 50 selective serotonin 50 5 alpha reductase 50 REMINYL ® 50 UNCERTAINTY OF FUTURE FINANCIAL 50 Elitek 50 coenzyme 50 phase IIb trial 50 Incretin 50 anticholinergics 50 5 HT6 50 aurora kinase 50 endothelial nitric oxide 50 p# MAPK 50 adrenal hormone 50 amylin 50 ALB # 50 urocortin 50 sipuleucel T 50 investigational oral 50 proteinase 50 G#DT 50 pegylated interferons 50 Ambrisentan 50 cyclin dependent kinase 50 Talotrexin 50 5 HT6 receptor 50 FLT3 50 p# biomarker 50 follicular lymphomas 50 vasodilators 50 transcriptional repressor 50 vanilloid receptor 50 Telintra 50 potent vasoconstrictor 50 opioid induced bowel dysfunction 50 AEG# 50 thrombospondin 50 5 HT2C receptor 50 ceftazidime 50 receptor antagonist 50 Cochrane Database Syst Rev. 50 T#I [002] 50 adrenergic receptor 50 Reductase 50 receptor PPAR 50 Ceflatonin R 50 glucokinase 50 cholesteryl ester transfer 50 adrenergic agonists 50 Zavesca R 50 Non inferiority 50 activin 50 ALN PCS 50 Anavex #-# 50 CDK5 50 doxercalciferol 50 LPA1 50 5 HT2A inverse 50 elotuzumab 50 TFPI 50 TRIOLEX 50 Angiotensin converting enzyme ACE 50 mitogenic 50 MEK inhibitor 50 STRIDE PD 50 antidiabetic drugs 50 Donepezil 50 DDP# 50 mg q#h 50 CIP TRAMADOL ER 50 INTEGRILIN 50 IFNg 50 receptor alpha 50 menadione 50 TGF Beta 50 adrenergic 50 PrevOnco 50 thromboxane A2 50 Xcytrin R 50 aquaporin